Sodium salicylate - CAS 54-21-7

Sodium Salicylate(Cat No.: A001025) is the sodium salt of salicylic acid. As a nonsteroidal anti-inflammatory drug (NSAID), sodium salicylate irreversibly acetylates cyclooxygenases I and II, thereby inhibiting prostaglandin synthesis and associated inflammation and pain. This agent may also activate mitogen-activated protein kinase (p38MAPK), thereby inducing apoptosis in cancer cells.

Catalog Number: A001025

CAS Number: 54-21-7

Molecular Formula: C7H5NaO3

Molecular Weight:160.10

Purity: ≥95%

* For research use only. Not for human or veterinary use.

Synonym

SynonymsSodium 2-hydroxybenzoate

Property

Molecular Formula: C7H5NaO3
Molecular Weight160.10
Target:NF-κB
Solubility>7.1mg/mL in DMSO
Purity≥95%
StorageRT
Overview of Clinical ResearchOriginator: Catabasis Pharmaceuticals<br /> Developer: Catabasis Pharmaceuticals; Sarepta Therapeutics<br /> Class: Amides; Anti-inflammatories; Antihyperglycaemics; Docosahexaenoic acids; Drug conjugates; Non-opioid analgesics; Salicylates; Small molecules<br /> Mechanism of Action: NF-kappa B inhibitors<br /> Orphan Drug Status: Yes – Duchenne muscular dystrophy<br /> New Molecular Entity: Yes

Computed Descriptor

IUPAC Namesodium;2-hydroxybenzoate
InChIInChI=1S/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1
InChIKeyABBQHOQBGMUPJH-UHFFFAOYSA-M
SMILESC1=CC=C(C(=C1)C(=O)[O-])O.[Na+]